Company

MOMA Therapeutics, Inc.

MOMA Therapeutics develops precision medicines that target molecular machines involved in human disease, based in Brighton, US.

About

Founded in 2020 and headquartered in Brighton, US, MOMA Therapeutics works on precision medicines that target molecular machines in various human diseases. Asit Parikh serves as CEO, and founder Timur Yusufzai has a background in other entrepreneurial ventures. The company has completed 2 deals, most recently a Series B of USD 150.00 mn on May 10, 2022, led by Goldman Sachs Merchant Banking Division. The Series B funding is intended to advance multiple precision oncology programs in the clinic.

2Funding rounds

9Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in